Everything-But-CRM Growth Drivers Slow In Q2 For St. Jude

Amid a persistently contracting cardiac rhythm management market, the firm’s CRM business, while not growing, performed better than expected in the second quarter. But several of it its non-CRM businesses, which the company relies on to drive growth, experienced a slowdown.

More from Archive

More from Medtech Insight